跳至主要内容
临床试验/ISRCTN12547806
ISRCTN12547806已完成未知

Effects of coffee drinking on glucose metabolism, cytokines and gastrointestinal hormone secretion: a single-blind randomised controlled trial

Physiologic Effects of Coffee Committee (PEC) (Netherlands)0 个研究点目标入组 49 人开始时间: 2009年7月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
49

研究概览

简要总结

2019 results in: https://doi.org/10.1007/s00394-019-02009-1 (added 04/06/2019)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • For inclusion in this trial subjects must fulfill all of the following criteria:
  • 1. Written informed consent to participate in this trial
  • 2. All drugs which may interfere with glucose metabolism must be discontinued. These include all medication for diabetes, asthma, heart diseases and stomach. Regular non-steroidal anti-inflammatory drug (NSAID) use must also be discontinued.
  • 3. Men and women aged less than 65 years (no lower age limit)
  • 4. Normal fasting insulin level
  • 5. 13 points as a result in the diabetes risk score
  • 6. 7.0 - 12.0 mmol/l as 2-hour blood glucose value in the OGTT

排除标准

  • Any of the following is regarded as a criterion for exclusion from the trial:
  • 1. Deterioration any of base examination which reveal diabetic state
  • 2. Persons with previous diagnosis of diabetes mellitus
  • 3. Use of drugs, which interfere with glucose metabolism or receiving treatment to lower blood glucose
  • 4. Pregnant women and women who are breast feeding
  • 5. History of malignancy, which needs any therapeutic intervention
  • 6. History of any chronic diseases or other medical characteristics likely to interfere with participation in the study
  • 7. Subjects with imbalanced clinical conditions, such as thyroid and liver diseases, which could interfere with glucose metabolism
  • 8. History of alcohol or drug abuse, or both

研究者

发起方
Physiologic Effects of Coffee Committee (PEC) (Netherlands)

相似试验